Sectoral Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Sectoral Asset Management’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-969,350	Closed	-$3.04M	–	118
2023 Q3	$3.04M	Buy	969,350 +166,670	+21%	+$682K	0.59%	74
2023 Q2	$4.14M	Buy	+802,680	New	+$4.77M	0.69%	63

Other funds holding OCUL

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Sectoral Asset Management's OCUL Position: Q4 2023 in Review

Sectoral Asset Management sold out of Ocular Therapeutix (OCUL) in Q4 2023, closing a stake of 969,350 shares — an estimated $3.04M sold.

Sectoral Asset Management first reported a position in OCUL in Q2 2023 and held it in 2 quarters. The position peaked at $4.14M in Q2 2023. 118 funds tracked by Wall St. Rank hold OCUL as of Q4 2023.

Sectoral Asset Management reported no remaining Ocular Therapeutix position as of Q4 2023 after selling out during the quarter.
Sectoral Asset Management sold 969,350 Ocular Therapeutix shares in Q4 2023, an estimated $3.04M.
Sectoral Asset Management first reported a position in Ocular Therapeutix in Q2 2023 and held it in 2 quarters.
Sectoral Asset Management's Ocular Therapeutix position peaked at $4.14M in Q2 2023.
118 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2023.

Based on Sectoral Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.